Accelerating the transition to a toxicity pathway-based paradigm for chemical safety assessment through internationally coordinated research and technology development
Prof. Dr. Horst Spielmann
AXLR8 is a coordination action funded by the European Commission Directorate General for Research & Innovation (Health Directorate; Advanced Therapies and Systems Medicine Unit) under the 7th European RTD Framework Programme Health Theme.
AXLR8 will provide tools and opportunities for increased networking, information exchange, problem solving, strategic planning and collaboration among a variety of scientific disciplines and stakeholder groups with the goal to accelerate the transition to a toxicity pathway-based paradigm for chemical safety assessment. AXLR8 will act as a focal point for coordination among 3Rs research projects in Europe as well as internationally.